AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-68 Cr | ₹47 Cr | ₹-201 Cr | ₹124 Cr | ₹28 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AJANTA PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-68 Cr |
| Mar2025 | ₹47 Cr |
| Mar2024 | ₹-201 Cr |
| Mar2023 | ₹124 Cr |
| Mar2022 | ₹28 Cr |
How is Net Cash Inflow / Outflow of AJANTA PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-68 Cr | Negative | |
| Mar2025 | ₹47 Cr | Positive | |
| Mar2024 | ₹-201 Cr | Negative | |
| Mar2023 | ₹124 Cr | 345.56 | |
| Mar2022 | ₹28 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹45,939.4 Cr | 4.7% | 6.6% | 38.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 4.7% |
6.6% |
38.2% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses